510 related articles for article (PubMed ID: 17613573)
21. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
23. Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance.
Schyns F; Paul L; Finlay K; Ferguson C; Noble E
Clin Rehabil; 2009 Sep; 23(9):771-81. PubMed ID: 19561035
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
25. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
Ashford S; Turner-Stokes L
Disabil Rehabil; 2009; 31(3):220-6. PubMed ID: 18608366
[TBL] [Abstract][Full Text] [Related]
26. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury].
Xing ST; Wang D; Wen XH; Wu ZQ; Sun Q; Zhang DW; Cheng Y; Yan D; Yu F
Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
28. [Botulinum toxin: a new dimension for spasticity].
Reichel G
MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
[TBL] [Abstract][Full Text] [Related]
29. Treatment of spasticity with botulinum toxin: a double-blind study.
Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
31. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
[TBL] [Abstract][Full Text] [Related]
32. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
[TBL] [Abstract][Full Text] [Related]
33. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
Wallen M; O'Flaherty SJ; Waugh MC
Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
[TBL] [Abstract][Full Text] [Related]
34. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy.
Moore AP; Ade-Hall RA; Smith CT; Rosenbloom L; Walsh HP; Mohamed K; Williamson PR
Neurology; 2008 Jul; 71(2):122-8. PubMed ID: 18606966
[TBL] [Abstract][Full Text] [Related]
35. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis].
Aguilar-Rebolledo F; Hernández-Sánchez J; Rayo-Mares D; Soriano-Fonseca F; García-Muñoz L; Ruiz-Ponce J; Garrido-Ramírez E
Gac Med Mex; 2001; 137(5):403-11. PubMed ID: 11692809
[TBL] [Abstract][Full Text] [Related]
36. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
[TBL] [Abstract][Full Text] [Related]
37. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
38. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
Carroll A; Barnes M; Comiskey C
Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study.
Gracies JM; Lugassy M; Weisz DJ; Vecchio M; Flanagan S; Simpson DM
Arch Phys Med Rehabil; 2009 Jan; 90(1):9-16.e2. PubMed ID: 19154823
[TBL] [Abstract][Full Text] [Related]
40. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
Turner-Stokes L; Ashford S
Disabil Rehabil; 2007 Dec; 29(23):1806-12. PubMed ID: 18033605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
